Serum CA-125: Biomarker of pulmonary tuberculosis activity and evaluation of response to treatment

Clinical and Investigative Medicine

Volumn 35, Issue 4, 2012, Pages

  Sahin, Fusun ^a   Yildiz, Pinar ^a  

^a Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CA 125 ANTIGEN;

ADULT; ARTICLE; BLOOD; CLINICAL TRIAL; FEMALE; HUMAN; LUNG TUBERCULOSIS; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

ADULT; BIOLOGICAL MARKERS; CA-125 ANTIGEN; FEMALE; HUMANS; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS, PULMONARY;

EID: 84867360800     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Daoud E. and Bodor G. CA-125 Concentrations in malignant and nonmalignant disease. Clinical Chemistry,1991;37(11):1968-1974.
2. Kabawat, S.E., Bast, R.C., Jr., Bhan, A.K., Welch W.R., Knapp R.C., Colvin R.B. Tissue distribution of a coelomic-epitheliumrelated antigen recognized by the monoclonal antibody OC125. Int. J. Gynecol. Pathol.,1983;2(3):275-285.
3. Takeshima F., Hamabe S., Yamasa T. Two cases of tuberculous peritonitis and clinical signi_cance of serum CA-125. Kekkaku, 1989;64(1):25-30.
4. Yoshimura T., Okamura H Peritoneal tuberculosis with elevated serum CA 125 levels: a case report. Gynecol Oncol. 1987;28(3):342-4.
5. Mitsutake Y., Hiromatsu Y, Saisho M. Immunological assay of the CA-125 value in pleural e_usion in various types of pleuritis-its application as a di_erentia diagnostic parameter of tuberculous or carcinomatous pleuritis. Gan No Rinsho. 1986;32(5):453-7.
6. Niwa Y., Shimokata K. Diagnostic significance of cancer antigen 125, pancreatic oncofetal antigen, and carcinoembryonic antigen in malignant and tuberculous pleural e_usions. Jpn J Clin Oncol., 1986;16(1):3-8.
7. Matsuoka Y., Endo K, Kawamura Y, Yoshida T, Saga T, Watanabe Y, Koizumi M, Nakashima T, Konishi J, Yamaguchi N. Normal bronchial mucus contains high levels of cancer associ-ated antigens, CA125, CA19-9, and carcinoembryonic antigen. Cancer 1990; 65: 506-10.
8. Tuxen M.K., Sölétormos G, Dombernowsky P. Tumor markers in the management of patients with ovarian cancer. Cancer Treat. Rev. 1995;21(3):215-45.
9. Jacobs I.J., Skates SJ, MacDonald N, Menon U, Rosenthal AN, Davies AP, Woolas R, Jeyarajah AR, Sibley K, Lowe DG, Oram DH. Screening for ovarian cancer: a pilot randomised controlled trial. Lancet 1999 Apr 10;353(9160):1207-10.
10. Khokhar N. High CA-125 Level in cirrhosis of the liver. Pak.J.Med.Sci.2002;18(3):254-256.
11. Diez M., Torres A., Pollan M., Gomez A., Ortega D., Maestro M.L., Granell J., Balibrea J.L. Prognostic significance of serum CA-125 antigen assay in patients with non-small cell lung cancer. Cancer,1994;73(5):1368-76.
12. Sulaiman S., Tan K.H. Markedly-elevated serum Ca-125 in a woman with pulmonary tuberculosis. Singapore Med. J. 2009;50(1):39-40.
13. Bilgin T., Karabay A., Dolar E., Develioglu OH. Peritoneal tuberculosis with pelvic abdominal mass, ascites and elevated CA-125 mimicking advanced ovarian carcinoma. A series of 10 cases. Int.J. Gynecol. Cancer,2001;11(4):290-4.
14. Simsek H., Savas MC., Kadayi{dotless}fçi{dotless} A., Tatar G. Elevated serum CA-125 concentration in patients with tuberculous peritonitis: A case-control study. Am. J. Gastroenterol., 1997; 92(7):1174-76.
15. Elias J., Kew M.C. Evaluation of CA-125 as a serum marker of hepatocellular carcinoma. Int. J. Cancer,1990;46(5):805-807.
16. Sharma S., Bose M. Role of cytokines in immune response to pulmonary tuberculosis. Asian. Pac. J. Allergy Immunol., 2001;19(3):213-9.
17. Jo E.K., Park J.K., Dockrell H.M. Dynamics of cytokine generation in patients with active pulmonary tuberculosis. Curr. Opin. Infect. Dis., 2003;16(3):205-10.
18. Ameglio F., Giannarelli D., Cordiali-Fei P., Pietravalle M, Alemanno L, Paone G, Amicosante M, Saltini C, Bisetti A. Use of Discriminant Analysis to Asses Disease Activity in Pulmonary Tuberculosis with a Panel of Specific and Nonspecific Serum Markers. Am.J.Clin.Pathol.,1994;101(6):719-725.
19. Bast RC, Jr, Feeney M, Lazarus H, Nadler LM, Colvin RB, Knapp RC. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest. 1981;68(5):1331-1337.
20. Frederick Hecht, William C. Shiel, Jr. Webster's New World Medical Dictionary. Second Edition, Wiley Publishing, Inc., ISBN:0-7645-2461-5, Jan 2003.
21. Eltabbakh GH., Gupta MK., Belinson JL., Kennedy AW, Webster K, Paraiso MF. Comparison Between Centcor CA 125 and CA 125 II Assays. Eur.J.Gynecol.Oncol., 1996;17(6):504-6.
22. Miralles C., Orea M., Espana P., Provencio M, Sánchez A, Cantos B, Cubedo R, Carcereny E, Bonilla F, Gea T. Cancer Antigen 125 Associated with Multiple Benign and Malignant Pathologies. Annals of Surgical Oncology,2003;10(2):150-4.
23. Bischof P. What Do We Know About the Origin of CA-125 Eur. J.Obstet. Gynecol. Reprod. Biol.,1993;49(1-2):93-8
24. Jimenez Perez C., Torres Leon JM., Martinez Alonso M, González Arias R, Benito Sánchez F, De la Torre Gutiérrez S, Torres Salcines J, Montero Vázquez JM. Peritoneal Tuberculosis: Evaluation of the Responseto Treatment Analysing the CA-125 Levels. Rev.Esp.Enferm.Dig.,1998;90(8):592-3.
25. Ronay G., Jager W., Tulusan AH. Immunohistochemical and SerologicDetection of CA-125 in Patients with Peritoneal Tuberculosis and Ascites. Geburtshilfe Frauenheilkd. 1989; 49(1):61-3.
26. Klein M., Marczewski A., Rosen A., BeckA. High CA-125 Values in Miliary Tuberculosis and Ascites. Wien.Klin.Wochenschr.,1989;101(24):870-1.
27. Mizutani H., Horiba M., Shindoh J., Kimura T, Son M, Wakahara K. A Case of Tuberculous Peritonitis Diagnosed by a Direct Smear Ascitic Fluid Complicated with an Active Pulmonary Tuberculosis and Intestinal Tuberculosis. Kekkaku.,2001;76(6):479-84.
28. Hasanzadeh M., Malekoti H. Miliary Tuberculosis Peritonitis Mimicking Advanced Ovarian Cancer. Cancer Therapy,2005;3:29-30.
29. Thakur V, Mukherjee U, Kumar K. Elevated serum cancer antigen 125 levels in advanced abdominal tuberculosis.Med.Oncol. 2001;18(4):289-91.
30. Wongtim S., Silachamroon U., Ruxrungtham K., Udompanich V, Limthongkul S, Charoenlap P, Nuchprayoon C. Interferon Gamma for Diagnosing Tuberculous Pleural Effusions. Thorax,1999;54(10):921-924.
31. Aoki Y., Katoh O., Nakanishi Y., Kuroki S, Yamada H. A Comparison Study of IFN-gamma, ADA and CA-125 as the Diagnostic Parameters in Tuberculous Pleuritis. Respir.Med.,1994;88(2):139-43.
32. Sen NS, Bayramgürler B, Akçiçek F, Baran R. Value of Ca-125 in the evaluation of tuberculous pleurisy. Akciger Arsivi,2001; 2:59-63.Turkish.
33. Huang WC, Tseng CW, Chang KM, Hsu JY, Chen JH, Shen GH. Usefulness of Tumor Marker CA-125 Serum Levels for the Follow-Up of Therapeutic Responses in Tuberculosis Patients with and without Serositis. Jpn J InfectDis. 2011;64(5):367-72.
34. Ichiki H., Shishido M., Nishitani K., Takatsugi K, Nishiyama S, Yano M, Watanabe K. Evaluation of CEA, SLX and CA-125 in Active Pulmonary Tuberculosis. Nihon Kyobu Shikkan Gakkai Zasshi.1993;31(12):1522-7.
35. Fortún J, Martín-Dávila P, Méndez R, Norman F, Rubi J, Pallares E, Gómez-Mampaso E, Moreno S. Ca-125: a useful marker to distinguish pulmonary tuberculosis from other pulmonary infections. OpenRespir Med J. 2009;3:123-7.